PEER REVIEWED, EVIDENCE-BASED INFORMATION FOR CLINICIANS AND RESEARCHERS IN NEUROSCIENCE

Category: Schizophrenia

Letters to the Editor

Letter to the Editor: Responding to correspondence on “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Citrome is a

June 1, 2024 No Comments

Letters to the Editor

Letter to the Editor: Response to “Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes”

Innov Clin Neurosci. 2024;21(4–6):8–10. Funding/financial disclosures. Dr. Zaragoza Domingo is

June 1, 2024 No Comments

Original Research

Functioning and Cognition in Patients with Schizophrenia After Initiating Treatment with Aripiprazole Lauroxil: Secondary Outcomes and Post Hoc Analysis

by Mark G. A. Opler, PhD, MPH; Amy Claxton, PhD*;

March 1, 2024 No Comments

Case Report

Genesis of Mental Disorders: Could It Be Cavum Septum Pellucidum (CSP) et Vergae? A Case Report of CSP in Schizophrenia with Catatonia

by Allison Zuckerberg, MD; Nitin Pothen, MD; and Adriana Fitzsimmons,

March 1, 2024 No Comments

Past Articles

Clinical Outcome Assessment Instruments in Schizophrenia: A Scoping Literature Review with a Focus on the Potential of Patient-reported Outcomes

by Leslie Citrome, MD, MPH; Marko A. Mychaskiw, BSRPh, MS,

June 1, 2023 No Comments

Letters to the Editor

Letter to the Editor: Open Bite Malocclusion Following Aripiprazole Treatment in Children and Adolescents

Funding/financial disclosures. The author has no conflicts of interest relevant

June 1, 2023 No Comments

Current Issue

Xanomeline and Trospium: A Potential Fixed Drug Combination (FDC) for Schizophrenia—A Brief Review of Current Data

by Alok Singh, MD Dr. Singh is with All India

December 1, 2022 No Comments

Current Issue

Impact of Lurasidone on Metabolic Parameters and Prolactin Levels Based on Differences of Psychiatric Diagnosis, Dosage, and Introducing Methods: An Observational Study

by Masaru Nakamura, MD, PhD, and Takahiko Nagamine, MD, PhD

April 1, 2022 No Comments

Original Research

Effects of Clozapine on Neurocognitive Functions in Schizophrenia: A Naturalistic Comparison to Non-clozapine Antipsychotics

by JP Lindenmayer, MD; Beverly J. Insel, PhD; Anzalee Khan,

October 1, 2021 No Comments

Case Report

Anatomical Association Between Schizophrenia and Cerebellum

by Rajashekar Reddy Yeruva, MD; Yafei Shang, MD; Ben Schoenbachler,

July 1, 2021 No Comments

LATEST DIGITAL EDITION

ARCHIVES

Innovations in Clinical Neuroscience is a subsidiary of Matrix Medical Communications

contact

Links

About

Topics

©2024 Matrix Medical Communications copyright all right reserved.

Site Design by: Dynamic Wave Consulting